Pfizer shares experienced a healthy 7.71% gain today as the company announced a patent victory on its biggest selling drug. This stock is technically interesting because it gapped up toward the combined resistance of the October highs and the 200 DMA. These levels have prevented the bulls from pushing the price higher on several previous occasions, and we believe that this may be the case again.



PFE_121905.jpg

You May Also Like

Related Analysis
  1. Entrepreneurship

    5 Hot Startup Industries Other Than Tech

  2. Personal Finance

    Home Depot Vs. Lowes: The Home Improvement Battle

  3. Personal Finance

    Insurance Companies Vs. Banks: Separate And Not Equal

  4. Chart Advisor

    3 ETFs Poised For A Move Higher

  5. Charts & Patterns

    Target Vs. Walmart: Who's Winning The Big Box War?

Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!